Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: The Palestinian Diabetes Complications and Control Study (PDCCS)

• Published in: Primary care diabetes 2018-12, Vol.12 (6), p.547-557
• Main Authors: Ghandour, Rula, Mikki, Nahed, Abu Rmeileh, Niveen M.E., Jerdén, Lars, Norberg, Margareta, Eriksson, Jan W., Husseini, Abdullatif
• Format: Article
• Language: English
• Subjects: Adult; anticoagulant agent; antidiabetic agent; antihypertensive agent; antilipemic agent; Arab; Arabs; biological marker; Biomarkers; blood; Blood Glucose; cardiac agent; cerebrovascular accident; Comorbidity; controlled study; coronary artery disease; Cross-Sectional Studies; cross-sectional study; Diabetes Complications; Diabetes Mellitus; diabetic complication; diabetic nephropathy; diabetic neuropathy; disease duration; epidemiology; ethnology; Female; glucose blood level; Glycated Hemoglobin A; Glycemic control; glycosylated hemoglobin; Health and Welfare; hemoglobin A1c; hemoglobin A1c protein; human; Humans; Hälsa och välfärd; insulin; laboratory test; Macrovascular complications; major clinical study; Male; metabolism; Microvascular complications; Middle Aged; Middle East; non insulin dependent diabetes mellitus; Palestinian; peripheral vascular disease; physical examination; Prevalence; Primary health care clinics; priority journal; risk factor; Risk Factors; Type 2; Type 2 diabetes; Young Adult
• ISSN: 1751-9918; 1878-0210; 1878-0210
• DOI: 10.1016/j.pcd.2018.07.002

•Persons with type 2 diabetes in 11 primary health care clinics were sampled.•Over three-quarters of the participants had at least one complication.•67% had at least one microvascular and 29% had at least 1 macrovascular complication.•Around one fifth of the participants had good glycemic control (HbA1c